Topics and Faculty

Review Long-Term Treatment Options for Patients with DES
Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP (Chairman) Associate Director, Cardiovascular Coordinating Center Staff, Cardiac, Peripheral, and Carotid Intervention Associate Professor of Medicine Department of Cardiovascular Medicine Cleveland Clinic Cleveland, OH

Review Recent Safety Data on DES and BMS
Christopher P. Cannon, MD Associate Professor of Medicine Harvard Medical School Associate Physician, Cardiovascular Division Brigham and Women’s Hospital Researcher Physician TIMI Study Group Boston, MA

Discuss Issues with Subacute Thrombosis in DES Patients
Bob Harrington, MD, FACC, FSCAI Director, Duke Clinical Research Institute Professor of Medicine Duke University Medical Center Durham, NC

---

Target Audience

This activity has been developed for clinical cardiologists, interventional cardiologists, radiologists and allied healthcare professionals working in cardiac and vascular labs.

---

Learning Objectives

Upon completion of this educational activity, participants should be able to:

• Explain the predictors of stent thrombosis
• Understand differences between bare metal stents and drug eluting stents
• Discuss the appropriate role of antiplatelet therapy and stents
• Describe the pharmacology of different antithrombotic drugs in patients undergoing percutaneous coronary interventions (PCI)
• Review current clinical trials regarding antiplatelet therapy
• Utilize current guidelines for use of antithrombotic therapy in PCI.

---

Accreditation

MD/DO: This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Nurses: ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour. Provider #: 110-3-E-06. Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.

Technologists: Approved for 1 credit hour by the SICP.

---

Faculty disclosures

All faculty participating in continuing education programs sponsored by NACCME are expected to disclose to the meeting audience any real or apparent conflict( s) of interest related to the content of their presentations. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations. Full faculty disclosures will be made at the beginning of the activity.

---

Commercial Supporter

This activity is supported by an educational grant from Bristol-Myers Squibb/Sanofi Pharmaceuticals.

---

Sponsor

The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).